These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 8540727)
1. Biochemical basis for increased susceptibility to Cidofovir of herpes simplex viruses with altered or deficient thymidine kinase activity. Mendel DB; Barkhimer DB; Chen MS Antimicrob Agents Chemother; 1995 Sep; 39(9):2120-2. PubMed ID: 8540727 [TBL] [Abstract][Full Text] [Related]
2. Genotypic and phenotypic characterization of the thymidine kinase of ACV-resistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain. Saijo M; Suzutani T; De Clercq E; Niikura M; Maeda A; Morikawa S; Kurane I Antiviral Res; 2002 Dec; 56(3):253-62. PubMed ID: 12406508 [TBL] [Abstract][Full Text] [Related]
3. Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation. Venard V; Dauendorffer JN; Carret AS; Corsaro D; Edert D; Bordigoni P; Le Faou A Pathol Biol (Paris); 2001 Sep; 49(7):553-8. PubMed ID: 11642018 [TBL] [Abstract][Full Text] [Related]
5. Successful treatment of an acyclovir- and foscarnet-resistant herpes simplex virus type 1 lesion with intravenous cidofovir. LoPresti AE; Levine JF; Munk GB; Tai CY; Mendel DB Clin Infect Dis; 1998 Feb; 26(2):512-3. PubMed ID: 9502489 [No Abstract] [Full Text] [Related]
6. Hydroxyurea enhances the activity of acyclovir and cidofovir against herpes simplex virus type 1 resistant strains harboring mutations in the thymidine kinase and/or the DNA polymerase genes. Sergerie Y; Boivin G Antiviral Res; 2008 Jan; 77(1):77-80. PubMed ID: 17913252 [TBL] [Abstract][Full Text] [Related]
7. Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses. Smee DF; Sidwell RW; Kefauver D; Bray M; Huggins JW Antimicrob Agents Chemother; 2002 May; 46(5):1329-35. PubMed ID: 11959564 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and antiviral activity of (S)-9-[4-hydroxy-3-(phosphonomethoxy)butyl]guanine. Kim CU; Luh BY; Martin JC J Med Chem; 1990 Jun; 33(6):1797-800. PubMed ID: 2160539 [TBL] [Abstract][Full Text] [Related]
9. Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus. Smee DF; Barnett BB; Sidwell RW; Reist EJ; Holy A Antiviral Res; 1995 Jan; 26(1):1-9. PubMed ID: 7741517 [TBL] [Abstract][Full Text] [Related]
10. Virus-drug resistance: thymidine kinase-deficient (TK-) mutants of herpes simplex virus. Therapeutic approaches. de Clercq E Ann Ist Super Sanita; 1987; 23(4):841-7. PubMed ID: 2837935 [No Abstract] [Full Text] [Related]
11. Cidofovir use in acyclovir-resistant herpes infection. Martinez CM; Luks-Golger DB Ann Pharmacother; 1997 Dec; 31(12):1519-21. PubMed ID: 9416391 [TBL] [Abstract][Full Text] [Related]
12. Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple-log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication in vitro. Beadle JR; Hartline C; Aldern KA; Rodriguez N; Harden E; Kern ER; Hostetler KY Antimicrob Agents Chemother; 2002 Aug; 46(8):2381-6. PubMed ID: 12121908 [TBL] [Abstract][Full Text] [Related]
13. Effect of (S)-1-[(3-hydroxy-2-phosphonyl methoxy) propyl] cytosine on the replication and morphogenesis of herpes simplex virus type 1. Chatterjee S; Burns P; Whitley RJ; Kern ER Antiviral Res; 1992 Sep; 19(3):181-92. PubMed ID: 1332603 [TBL] [Abstract][Full Text] [Related]
14. Sequence changes in the human adenovirus type 5 DNA polymerase associated with resistance to the broad spectrum antiviral cidofovir. Kinchington PR; Araullo-Cruz T; Vergnes JP; Yates K; Gordon YJ Antiviral Res; 2002 Oct; 56(1):73-84. PubMed ID: 12323401 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory activity of alkoxyalkyl and alkyl esters of cidofovir and cyclic cidofovir against orthopoxvirus replication in vitro. Keith KA; Wan WB; Ciesla SL; Beadle JR; Hostetler KY; Kern ER Antimicrob Agents Chemother; 2004 May; 48(5):1869-71. PubMed ID: 15105146 [TBL] [Abstract][Full Text] [Related]
16. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model. Coen DM; Irmiere AF; Jacobson JG; Kerns KM Virology; 1989 Feb; 168(2):221-31. PubMed ID: 2536980 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of acyclic nucleoside phosphonates against herpes virus replication. Neyts J; De Clercq E Biochem Pharmacol; 1994 Jan; 47(1):39-41. PubMed ID: 8311844 [TBL] [Abstract][Full Text] [Related]
18. Comparative activity of various compounds against clinical strains of herpes simplex virus. Andrei G; Snoeck R; Goubau P; Desmyter J; De Clercq E Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):143-51. PubMed ID: 1327785 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiviral activity of the nucleotide analogue (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine. Bronson JJ; Ghazzouli I; Hitchcock MJ; Webb RR; Martin JC J Med Chem; 1989 Jul; 32(7):1457-63. PubMed ID: 2544723 [TBL] [Abstract][Full Text] [Related]